1998
DOI: 10.1016/s0378-4347(97)00645-2
|View full text |Cite
|
Sign up to set email alerts
|

High-performance liquid chromatography analysis of Bobel-24 in biological samples for pharmacokinetic, metabolic and tissue distribution studies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
7
0

Year Published

2004
2004
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(7 citation statements)
references
References 4 publications
0
7
0
Order By: Relevance
“…As Bobel-24 was originally introduced and described as a COX and LOX inhibitor (31,33), we asked whether these inhibitions were responsible for the cytotoxic activity. We analyzed whether Bobels interfered with the arachidonic acid metabolism by analyzing metabolites of arachidonic acid in K562 (myeloid cell line) and Raji (lymphoid cell line).…”
Section: Bobel-16 and Bobel-4 Cause The Lowest Survival On Leukemia Cmentioning
confidence: 99%
“…As Bobel-24 was originally introduced and described as a COX and LOX inhibitor (31,33), we asked whether these inhibitions were responsible for the cytotoxic activity. We analyzed whether Bobels interfered with the arachidonic acid metabolism by analyzing metabolites of arachidonic acid in K562 (myeloid cell line) and Raji (lymphoid cell line).…”
Section: Bobel-16 and Bobel-4 Cause The Lowest Survival On Leukemia Cmentioning
confidence: 99%
“…[10][11][12] Some iodinated compounds have found application in the pharmaceutical field and recently a new drug based on 2,4,6-triiodophenol (2,4,6-triiodophenol or Bobel-24) has been proposed as an anti-inflammatory. 13 This compound has been shown to possess anti-inflammatory properties through in vivo tests in different animal models. Some interesting properties have been described for phenolic compounds.…”
Section: Introductionmentioning
confidence: 99%
“…It has been found that 2,4,6-triiodophenol is a 5-lipoxygenase inhibitor, which could be effective in the therapy of inflammatory diseases mediated by leukotrienes. 13 Presently, studies are being carried out to demonstrate Bobel-24 is effective in the treatment of articular diseases and seborrheic dermatitis in dogs. 13 The development of such studies requires not only a reliable and fast analytical method but also a sensitive technique capable of determining 2,4,6-triiodophenol and its possible metabolites and degradation products in different types of biological samples.…”
Section: Introductionmentioning
confidence: 99%
“…Bobel-24 is a nonsteroidal antiinflammatory compound ( Fig. 1) (6,10,11). It is under clinical development as a potent leukotriene B 4 synthesis inhibitor (17).…”
mentioning
confidence: 99%